These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3917587)
21. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919 [TBL] [Abstract][Full Text] [Related]
22. Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease. Deeg HJ; Storb R; Thomas ED Surv Immunol Res; 1982; 1(2):148-54. PubMed ID: 6764839 [TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation, Part II, Immunogenetics of rat bone marrow transplantation. Bennett M; Rodday P; Williams RM Surv Immunol Res; 1982; 1(2):144-7. PubMed ID: 6138829 [No Abstract] [Full Text] [Related]
24. Long-term donor chimerism after MHC (RT1) mismatched bone marrow transplantation in the rat: the role of host alloreactive NK cells. Engh E; Strøm-Gundersen I; Benestad HB; Rolstad B Scand J Immunol; 2001; 54(1-2):198-203. PubMed ID: 11439167 [TBL] [Abstract][Full Text] [Related]
25. Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells. Chowdhury NC; Jin MX; Oluwole SF Transplantation; 1993 Jun; 55(6):1229-35. PubMed ID: 8516807 [TBL] [Abstract][Full Text] [Related]
26. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Shizuru JA; Jerabek L; Edwards CT; Weissman IL Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349 [TBL] [Abstract][Full Text] [Related]
27. Ex vivo treatment of murine splenocyte-supplemented bone marrow inocula with mafosfamide prior to allogeneic transplantation in an attempt to prevent lethal graft-versus-host disease without compromising engraftment. Kohn FR; Sladek NE Immunopharmacol Immunotoxicol; 1988; 10(3):387-98. PubMed ID: 3058776 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow. Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532 [TBL] [Abstract][Full Text] [Related]
29. RT1.C and rat bone marrow transplantation. Klempnauer J; Marquarding E Transplant Proc; 1989 Apr; 21(2):3292-3. PubMed ID: 2652816 [No Abstract] [Full Text] [Related]
30. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation. Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404 [TBL] [Abstract][Full Text] [Related]
31. Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model. Chou SH; Chawla A; Lee TH; Zhou Y; Busch MP; Balassanian R; Ferrell L; Cowan MJ Transplantation; 2001 Dec; 72(11):1768-76. PubMed ID: 11740386 [TBL] [Abstract][Full Text] [Related]
32. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy. Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342 [TBL] [Abstract][Full Text] [Related]
33. Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients. Ladiges WC; Storb R; Raff RF; Appelbaum FR; Sandmaier B; Schuening F; Graham T Bone Marrow Transplant; 1990 Jan; 5(1):43-6. PubMed ID: 2297589 [TBL] [Abstract][Full Text] [Related]
34. Major histocompatibility complex control of NK-related allogeneic lymphocyte cytotoxicity in rats. The contributions of strong and medial transplantation antigens. Ager A; Fajumi J; Sparshott SM; Ford WL; Butcher GW Transplantation; 1988 Nov; 46(5):762-7. PubMed ID: 3194940 [TBL] [Abstract][Full Text] [Related]
35. Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes. Kanathezhath B; Mizokami M; Stanislaus S; Hounshell C; Neumayr L; Guo H; Hearst JE; Walters MC; Kuypers FA Exp Biol Med (Maywood); 2011 Apr; 236(4):492-504. PubMed ID: 21454375 [TBL] [Abstract][Full Text] [Related]
36. Polymorphic class II sequences linked to the rat major histocompatibility complex (RT1) homologous to human DR and DQ sequences. Palmer MJ; Buck DA; Frelinger JA; Wettstein PJ J Immunol; 1985 Aug; 135(2):1450-5. PubMed ID: 2989367 [TBL] [Abstract][Full Text] [Related]
37. Fas-deficient lpr mice are more susceptible to graft-versus-host disease. van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044 [TBL] [Abstract][Full Text] [Related]
38. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR; Majewski D; Hanson G Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102 [TBL] [Abstract][Full Text] [Related]
39. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD. Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353 [TBL] [Abstract][Full Text] [Related]
40. Genetic control of collagen-induced arthritis in rats: the immune response to type II collagen among susceptible and resistant strains and evidence for multiple gene control. Griffiths MM; DeWitt CW J Immunol; 1984 Jun; 132(6):2830-6. PubMed ID: 6202763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]